Clinical Trial Update: Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of capecitabine and oxaliplatin for metastatic nasopharyngeal carcinoma; the current status is not specif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: The University of Hong Kong | Conditions: Nasopharyngeal Neoplasms | Phase 2 | Status: UNKNOWN